Events & Presentations

Date	Event Details	Remind Me
Oct 5, 2023	2023 Annual Northeast Amyotrophic Lateral Sclerosis Consortium (NEALS) Meeting View Additional Information Type: Poster Presentation Title: Preclinical Profile of ARO-SOD1, an siRNA Therapy for SOD1-ALS	Add to Outlook Add to Google Calendar
Oct 10, 2023	BMO Biopharma Spotlight Series: (R) Evolution of RNA Therapies View Additional Information Type: Fireside Chat Presentation	Add to Outlook Add to Google Calendar
Oct 18, 2023	Cracking the Code: The Dawn of Nucleic Acid Medicines View Additional Information Type: Poster Presentation Title: Rank Order TRiMTM Activity Correlates with RISC Loading and Can Be Enhanced by cPrP Modification	Add to Outlook Add to Google Calendar
Oct 22, 2023	The 3rd International Research Conference on Neurodegenerative Diseases (IRCND 2023) View Additional Information Type: Oral Presentation Title: Preclinical Profile of ARO-SOD1, an siRNA Therapy for SOD1-ALS	Add to Outlook Add to Google Calendar

Date	Event Details
Nov 28, 2022 4:30 PM EST	Arrowhead Pharmaceuticals Fiscal 2022 Year End Results Listen to webcast Supporting Materials: Prepared Remarks 292.1 KB Live Teleconference Information Click here for dial-in information
Nov 9, 2022 10:00 AM EST	Virtual ARO-APOC3 and ARO-ANG3 Investor Event Listen to webcast Supporting Materials: View Presentation 8 MB
Nov 5 - Nov 7, 2022	American Heart Association (AHA) Scientific Sessions 2022 Supporting Materials: AHA 2022 AROAPOC3-2001 595.8 KB AHA 2022 AROANG3-2001 573.5 KB View Additional Information Title: ARO-ANG3, an Investigational RNAi Therapeutic, Decreases Serum Angiopoietin-Like Protein 3, Triglycerides, and Cholesterol in Patients With Mixed Dyslipidemia Date/Time: November 7, 2022, 3:00 p.m. CST Presenter: Robert S. Rosenson Session: The Present and Future of Lipid Lowering Title: ARO-APOC3, an Investigational RNAi Therapeutic, Decreases Serum Apolipoprotein C3, Triglyceride, and Non-HDL-C Concentrations While Increasing HDL-C in Patients With Severe Hypertriglyceridemia Date/Time: November 7, 2022, 3:08 p.m. CST Presenter: Christie M. Ballantyne Session: The Present and Future of Lipid Lowering
Oct 4, 2022 2:00 PM EDT	Chardan’s 6th Annual Genetic Medicines Summit Listen to webcast View Additional Information Type: Fireside chat presentation Presenter: Vincent Anzalone, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Sep 14, 2022 3:30 PM EDT	Morgan Stanley 20th Annual Global Healthcare Conference View Additional Information Note: Presentation Cancelled Type: Fireside chat presentation Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals
Sep 13, 2022 4:20 PM EDT	Baird 2022 Global Healthcare Conference Listen to webcast View Additional Information Type: Fireside chat presentation Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals
Sep 12 - Sep 14, 2022	H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022 View Additional Information Type: Fireside chat presentation Presenter: Christopher Anzalone, Ph.D., President and CEO, Arrowhead Pharmaceuticals
Sep 7 - Sep 9, 2022	2022 Wells Fargo Healthcare Conference View Additional Information Type: Investor meetings Presenter: Vincent Anzalone, CFA, Vice President Finance and Investor Relations, Arrowhead Pharmaceuticals
Sep 4 - Sep 6, 2022	European Respiratory Society (ERS) International Congress 2022 Supporting Materials: View Presentation 2.5 MB View Additional Information Title: Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats Presenter: Erik Bush, Ph.D., Group Vice President, Biology, Arrowhead Pharmaceuticals
Aug 4, 2022 4:30 PM EDT	Arrowhead Pharmaceuticals 2022 Third Quarter Results Listen to webcast Supporting Materials: Prepared Remarks 241.8 KB